🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/10/2016 | 59,90 | 60,11 | 59,19 | 59,90 | +0,18% | 1,53% | 11.292.410 |
| 06/10/2016 | 59,63 | 59,82 | 58,91 | 59,79 | -0,22% | 1,52% | 11.979.164 |
| 05/10/2016 | 59,83 | 60,15 | 59,62 | 59,92 | +0,54% | 0,89% | 8.249.122 |
| 04/10/2016 | 59,62 | 60,07 | 59,10 | 59,60 | -0,10% | 1,62% | 8.276.475 |
| 03/10/2016 | 59,37 | 59,70 | 58,85 | 59,66 | +0,18% | 1,45% | 7.881.065 |
| 30/09/2016 | 59,06 | 59,86 | 59,03 | 59,55 | +0,81% | 1,41% | 14.258.354 |
| 29/09/2016 | 60,13 | 60,13 | 58,74 | 59,07 | -2,20% | 2,32% | 11.454.640 |
| 28/09/2016 | 60,11 | 60,57 | 59,64 | 60,40 | +1,17% | 1,56% | 12.361.160 |
| 27/09/2016 | 59,46 | 59,83 | 59,00 | 59,70 | +0,68% | 1,40% | 7.693.158 |
| 26/09/2016 | 59,67 | 59,71 | 59,05 | 59,30 | -1,29% | 1,12% | 7.319.022 |
| 23/09/2016 | 59,99 | 60,35 | 59,83 | 60,08 | -0,10% | 0,87% | 8.048.430 |
| 22/09/2016 | 60,04 | 60,56 | 59,95 | 60,13 | +0,51% | 1,02% | 8.853.294 |
| 21/09/2016 | 59,41 | 59,94 | 59,03 | 59,83 | +1,23% | 1,54% | 7.565.512 |
| 20/09/2016 | 59,06 | 59,55 | 58,86 | 59,10 | +0,99% | 1,16% | 9.653.757 |
| 19/09/2016 | 59,68 | 59,68 | 58,51 | 58,52 | -1,53% | 1,95% | 11.829.510 |
| 16/09/2016 | 59,59 | 59,75 | 59,22 | 59,43 | -0,16% | 0,90% | 13.029.050 |
| 15/09/2016 | 58,44 | 59,74 | 58,32 | 59,52 | +1,68% | 2,43% | 9.429.694 |
| 14/09/2016 | 59,08 | 59,48 | 58,49 | 58,54 | -0,74% | 1,68% | 10.922.046 |
| 13/09/2016 | 59,51 | 59,90 | 58,56 | 58,98 | -2,18% | 2,26% | 10.714.123 |
| 12/09/2016 | 59,16 | 60,58 | 59,07 | 60,30 | +1,12% | 2,55% | 11.139.716 |
| 09/09/2016 | 59,82 | 59,84 | 59,47 | 59,63 | -1,19% | 0,62% | 13.191.700 |
| 08/09/2016 | 59,59 | 60,39 | 59,48 | 60,34 | +0,59% | 1,54% | 9.627.242 |
| 07/09/2016 | 60,41 | 60,58 | 59,73 | 59,99 | -0,58% | 1,41% | 9.084.169 |
| 06/09/2016 | 60,11 | 60,56 | 59,90 | 60,34 | +0,41% | 1,11% | 8.310.954 |
| 02/09/2016 | 59,72 | 60,37 | 59,72 | 60,10 | +0,13% | 1,09% | 7.978.634 |
| 01/09/2016 | 59,83 | 60,10 | 59,53 | 60,02 | +0,18% | 0,94% | 6.858.846 |
| 31/08/2016 | 60,19 | 60,23 | 59,56 | 59,91 | +0,13% | 1,11% | 9.285.804 |
| 30/08/2016 | 60,08 | 60,14 | 59,65 | 59,84 | -0,48% | 0,83% | 6.474.544 |
| 29/08/2016 | 60,04 | 60,39 | 59,77 | 60,12 | +0,25% | 1,03% | 5.843.438 |
| 26/08/2016 | 59,62 | 60,11 | 59,33 | 59,97 | +0,85% | 1,30% | 8.167.902 |